 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bethfj@merge.com
|
|
Kenneth D. Rardin
President and CEO
Merge Healthcare
414.977.4000
ir@merge.com
|
|
Merge Healthcare Announces Promotion of Senior Executive
to Merge Healthcare North America President
Milwaukee, WI, February 13, 2007 - Merge Technologies Incorporated, d.b.a. Merge Healthcare (NASDAQ: MRGE; TSX: MRG), today announced that Gary D. Bowers has been promoted to President, Merge Healthcare North America, reporting directly to Kenneth D. Rardin, President and CEO of Merge Healthcare, effective February 12, 2007. Mr. Bowers will manage the Merge Healthcare North America sales and business development channel, which provides medical imaging workflow software solutions to hospitals, imaging centers and specialty clinics throughout the United States of America and Canada. The role had been temporarily filled by Mr. Rardin prior to Mr. Bowers’ promotion.
Mr. Bowers joined Merge Healthcare in September 2006, serving as Senior Vice President, Strategic Business Initiatives, and most recently led Merge Healthcare's onshore/offshore development, service and support initiative in Pune, India. Previously, he was Senior Vice President, Product Technology for Park City Solutions, and was a General Partner of Rardin Capital Management, a technology and financial consulting firm. He also served in multiple senior executive roles at IMNET Systems, Incorporated. Mr. Bowers received a B.A. in Statistics from the University of Rochester.
"We have made good progress in expanding the footprint in the North American market with our RIS, PACS and clinical solutions, with more than 300 installations in the United States. We will leverage Mr. Bowers’ broad management and operations experience as Merge Healthcare continues to expand its market presence in 2007 and beyond," stated Mr. Rardin.
"I am delighted to have been chosen to lead Merge Healthcare North America at this stage in our growth," said Mr. Bowers. "Our product portfolio, leadership talent and dedicated customers have created the basis for our future successes, and I look forward to building upon that foundation."
###
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com .
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
